Benchmark analyst Bruce Jackson initiates coverage on Belite Bio (NASDAQ:BLTE) with a Buy rating and announces Price Target of $57.
Raymond James Maintains Outperform Rating for Old Dominion Freight Line: Here’s What You Need To Know
Raymond James has decided to maintain its Outperform rating of Old Dominion Freight Line (NASDAQ:ODFL) and raise its…